↓ Skip to main content

Dove Medical Press

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
22 Mendeley
Title
Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
Published in
Therapeutics and Clinical Risk Management, September 2019
DOI 10.2147/tcrm.s167452
Pubmed ID
Authors

Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 23%
Researcher 4 18%
Student > Master 3 14%
Lecturer 1 5%
Professor 1 5%
Other 1 5%
Unknown 7 32%
Readers by discipline Count As %
Medicine and Dentistry 9 41%
Chemical Engineering 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Business, Management and Accounting 1 5%
Other 2 9%
Unknown 7 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2023.
All research outputs
#8,540,769
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#462
of 1,323 outputs
Outputs of similar age
#140,963
of 350,007 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 13 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.